These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 8950048

  • 21. Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastases.
    Quintieri L, Rosato A, Amboldi N, Vizler C, Ballinari D, Zanovello P, Collavo D.
    Br J Cancer; 1999 Mar; 79(7-8):1067-73. PubMed ID: 10098738
    [Abstract] [Full Text] [Related]

  • 22. [Selective hepatic arterial infusion of liposomes containing antitumor agents].
    Kumai K, Takahashi T, Tsubouchi T, Yoshino K, Ishibiki K, Abe O.
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1946-8. PubMed ID: 4051510
    [Abstract] [Full Text] [Related]

  • 23. Anthracycline antibiotics with high liposome entrapment: structural features and biological activity.
    Perez-Soler R, Priebe W.
    Cancer Res; 1990 Jul 15; 50(14):4260-6. PubMed ID: 2194651
    [Abstract] [Full Text] [Related]

  • 24. [Anti-tumor effect of monkshood polysaccharide with adriamycin long circulating temperature-sensitive liposome and its mechanism].
    Dong LF, Zhang YJ, Liu JS, Song SX, Hou J, Lu ZJ.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul 15; 22(4):458-62. PubMed ID: 16806008
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Antitumor effect of adriamycin entrapped in liposomes conjugated with monoclonal antibody against tumor-associated antigen of bovine leukemia cells.
    Onuma M, Odawara T, Watarai S, Aida Y, Ochiai K, Syuto B, Matsumoto K, Yasuda T, Fujimoto Y, Izawa H.
    Jpn J Cancer Res; 1986 Nov 15; 77(11):1161-7. PubMed ID: 3025145
    [Abstract] [Full Text] [Related]

  • 27. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
    Allen TM, Mumbengegwi DR, Charrois GJ.
    Clin Cancer Res; 2005 May 01; 11(9):3567-73. PubMed ID: 15867261
    [Abstract] [Full Text] [Related]

  • 28. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
    Cui J, Li C, Guo W, Li Y, Wang C, Zhang L, Zhang L, Hao Y, Wang Y.
    J Control Release; 2007 Apr 02; 118(2):204-15. PubMed ID: 17239468
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Enhanced circulation time and antitumor activity of doxorubicin by comblike polymer-incorporated liposomes.
    Han HD, Lee A, Hwang T, Song CK, Seong H, Hyun J, Shin BC.
    J Control Release; 2007 Jul 31; 120(3):161-8. PubMed ID: 17524514
    [Abstract] [Full Text] [Related]

  • 32. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
    Gabizon A, Horowitz AT, Goren D, Tzemach D, Shmeeda H, Zalipsky S.
    Clin Cancer Res; 2003 Dec 15; 9(17):6551-9. PubMed ID: 14695160
    [Abstract] [Full Text] [Related]

  • 33. Activity of menogaril against various malignant lymphoma cell lines and a human lymphoma xenograft in mice.
    Yoshida M, Fujioka A, Nakano K, Yuasa C, Toko T, Takeda S, Unemi N.
    Anticancer Res; 1996 Dec 15; 16(5A):2875-9. PubMed ID: 8917401
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. In vitro and in vivo studies with anionic sulfatide-liposomes containing adriamycin.
    Cervato G, Viani P, Galatulas I, Bossa R, Cestaro B.
    Anticancer Res; 1986 Dec 15; 6(6):1287-90. PubMed ID: 3813484
    [Abstract] [Full Text] [Related]

  • 36. 4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent.
    Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1982 Apr 15; 42(4):1462-7. PubMed ID: 7060020
    [Abstract] [Full Text] [Related]

  • 37. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
    Lopes de Menezes DE, Pilarski LM, Allen TM.
    Cancer Res; 1998 Aug 01; 58(15):3320-30. PubMed ID: 9699662
    [Abstract] [Full Text] [Related]

  • 38. In-vitro cytotoxicity, in-vivo biodistribution and anti-tumour effect of PEGylated liposomal topotecan.
    Hao YL, Deng YJ, Chen Y, Wang KZ, Hao AJ, Zhang Y.
    J Pharm Pharmacol; 2005 Oct 01; 57(10):1279-87. PubMed ID: 16259756
    [Abstract] [Full Text] [Related]

  • 39. Antitumor effect of liposome-entrapped adriamycin administered via the portal vein.
    Ichino T, Yotsuyanagi T, Mizuno I, Akamo Y, Yamamoto T, Saito T, Kurahashi S, Tanimoto N, Yura J.
    Jpn J Cancer Res; 1990 Oct 01; 81(10):1052-6. PubMed ID: 2121678
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.